FDA Clears Immunoassays for Preeclampsia Risk Assessment
FDA has cleared two immunoassays for the risk assessment and clinical management of preeclampsia, a severe pregnancy complication.
Read MorePosted by Melanie Hamilton-Basich | May 22, 2023 | Immunoassay |
FDA has cleared two immunoassays for the risk assessment and clinical management of preeclampsia, a severe pregnancy complication.
Read MorePosted by Melanie Hamilton-Basich | May 22, 2023 | Molecular Diagnostics |
With AlphaID At Home, people can self-collect a small saliva sample to learn their risk of developing disease linked to alpha-1.
Read MorePosted by Chris Wolski | May 17, 2023 | Disease States |
Researchers have developed a liquid biopsy technique that may reveal signs of Parkinson’s disease in urine samples.
Read MorePosted by Chris Wolski | May 17, 2023 | Cardiovascular |
The BNP control is designed to be used alongside the Acusera range of third-party controls, providing a comprehensive package.
Read MorePosted by Melanie Hamilton-Basich | May 15, 2023 | Cervical (HPV) |
Sending HPV self-collection tests by mail and providing support to schedule in-clinic screening appointments for under-screened women increased cervical cancer screening rates by almost two times.
Read More